RS58919B1 - Imunogeni sastav koji sadrži polipeptide izvedene iz panton-valentin leukocidina (pvl) - Google Patents
Imunogeni sastav koji sadrži polipeptide izvedene iz panton-valentin leukocidina (pvl)Info
- Publication number
- RS58919B1 RS58919B1 RS20190664A RSP20190664A RS58919B1 RS 58919 B1 RS58919 B1 RS 58919B1 RS 20190664 A RS20190664 A RS 20190664A RS P20190664 A RSP20190664 A RS P20190664A RS 58919 B1 RS58919 B1 RS 58919B1
- Authority
- RS
- Serbia
- Prior art keywords
- panton
- pvl
- immunogenic composition
- derived polypeptides
- valentine leukocidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161566234P | 2011-12-02 | 2011-12-02 | |
| PCT/US2012/067483 WO2013082558A1 (en) | 2011-12-02 | 2012-11-30 | Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides |
| EP12854165.3A EP2785368B1 (en) | 2011-12-02 | 2012-11-30 | Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS58919B1 true RS58919B1 (sr) | 2019-08-30 |
Family
ID=48536149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20190664A RS58919B1 (sr) | 2011-12-02 | 2012-11-30 | Imunogeni sastav koji sadrži polipeptide izvedene iz panton-valentin leukocidina (pvl) |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10023848B2 (sr) |
| EP (1) | EP2785368B1 (sr) |
| JP (1) | JP6325452B2 (sr) |
| KR (1) | KR101999299B1 (sr) |
| AU (1) | AU2012345645B2 (sr) |
| CA (1) | CA2857666C (sr) |
| DK (1) | DK2785368T3 (sr) |
| ES (1) | ES2728445T3 (sr) |
| HR (1) | HRP20190907T1 (sr) |
| LT (1) | LT2785368T (sr) |
| RS (1) | RS58919B1 (sr) |
| SI (1) | SI2785368T1 (sr) |
| WO (1) | WO2013082558A1 (sr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2728445T3 (es) | 2011-12-02 | 2019-10-24 | Integrated Biotherapeutics Inc | Composición inmunogénica que comprende polipéptidos derivados de leucocidina de Panton-Valentine (PVL) |
| WO2014205127A2 (en) * | 2013-06-18 | 2014-12-24 | New York University | Cellular factors involved in the cytotoxicity of staphylococcus aureus leukocidins: novel therapeutic targets |
| WO2014205111A1 (en) | 2013-06-19 | 2014-12-24 | Integrated Biotherapeutics, Inc. | Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof |
| US9149521B2 (en) | 2013-09-25 | 2015-10-06 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| US20150086592A1 (en) | 2013-09-25 | 2015-03-26 | Sequoia Sciences, Inc | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| US9149522B2 (en) | 2013-09-25 | 2015-10-06 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| US9504743B2 (en) | 2013-09-25 | 2016-11-29 | Sequoia Sciences, Inc | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| JP6473746B2 (ja) * | 2013-10-17 | 2019-02-20 | アルサニス・バイオサイエンスズ・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 交差反応性黄色ブドウ球菌抗体配列 |
| WO2017026301A1 (ja) * | 2015-08-10 | 2017-02-16 | 株式会社微生物化学研究所 | 黄色ブドウ球菌不活化菌体とロイコシジンを混合したワクチン |
| CN107224575B (zh) * | 2017-03-06 | 2018-11-09 | 浙江海隆生物科技有限公司 | 奶牛金黄色葡萄球菌乳房炎亚单位疫苗的组合物及其制备方法和应用 |
| JP7303791B2 (ja) | 2017-07-27 | 2023-07-05 | アブヴァク インコーポレイテッド | スーパー抗原トキソイドに由来する融合ペプチドを含む免疫原性組成物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US20100158871A1 (en) | 1999-08-30 | 2010-06-24 | David Stephen Terman | Sickled erythrocytes with antitumor molecules induce tumoricidal effects |
| US20050008633A1 (en) | 2003-05-19 | 2005-01-13 | Advanced Inhalation Research Inc. | Chemical and physical modulators of bioavailability of inhaled compositions |
| CN102698261A (zh) * | 2005-06-13 | 2012-10-03 | 葛兰素史密斯克蓝生物品公司 | Panton-valentine杀白细胞素用于治疗和预防葡萄球菌感染的用途 |
| US7754225B2 (en) | 2006-07-20 | 2010-07-13 | Glaxosmithkline Biologicals S.A. | Method of protecting against staphylococcal infection |
| EP2082233B1 (fr) * | 2006-10-18 | 2012-10-31 | Biomerieux | Procede de diagnostic in vitro des staphylococcus aureus producteurs de pvl |
| ES2728445T3 (es) | 2011-12-02 | 2019-10-24 | Integrated Biotherapeutics Inc | Composición inmunogénica que comprende polipéptidos derivados de leucocidina de Panton-Valentine (PVL) |
-
2012
- 2012-11-30 ES ES12854165T patent/ES2728445T3/es active Active
- 2012-11-30 SI SI201231603T patent/SI2785368T1/sl unknown
- 2012-11-30 RS RS20190664A patent/RS58919B1/sr unknown
- 2012-11-30 US US14/362,298 patent/US10023848B2/en active Active
- 2012-11-30 DK DK12854165.3T patent/DK2785368T3/da active
- 2012-11-30 CA CA2857666A patent/CA2857666C/en active Active
- 2012-11-30 KR KR1020147018356A patent/KR101999299B1/ko active IP Right Grant
- 2012-11-30 WO PCT/US2012/067483 patent/WO2013082558A1/en active Application Filing
- 2012-11-30 JP JP2014544964A patent/JP6325452B2/ja active Active
- 2012-11-30 AU AU2012345645A patent/AU2012345645B2/en active Active
- 2012-11-30 EP EP12854165.3A patent/EP2785368B1/en active Active
- 2012-11-30 LT LTEP12854165.3T patent/LT2785368T/lt unknown
-
2019
- 2019-05-16 HR HRP20190907TT patent/HRP20190907T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140117381A (ko) | 2014-10-07 |
| ES2728445T3 (es) | 2019-10-24 |
| SI2785368T1 (sl) | 2019-08-30 |
| KR101999299B1 (ko) | 2019-07-12 |
| EP2785368A1 (en) | 2014-10-08 |
| JP2015505831A (ja) | 2015-02-26 |
| DK2785368T3 (da) | 2019-05-27 |
| NZ626762A (en) | 2016-07-29 |
| LT2785368T (lt) | 2019-06-10 |
| EP2785368A4 (en) | 2015-12-30 |
| EP2785368B1 (en) | 2019-03-13 |
| JP6325452B2 (ja) | 2018-05-16 |
| CA2857666C (en) | 2020-08-11 |
| WO2013082558A1 (en) | 2013-06-06 |
| HRP20190907T1 (hr) | 2019-07-12 |
| US20140308291A1 (en) | 2014-10-16 |
| AU2012345645B2 (en) | 2017-09-07 |
| AU2012345645A1 (en) | 2014-06-26 |
| US10023848B2 (en) | 2018-07-17 |
| CA2857666A1 (en) | 2013-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1231412A1 (zh) | 免疫原性組合物 | |
| EP2785368A4 (en) | IMMUNOGENIC COMPOSITION COMPRISING POLYPEPTIDES FROM PANTON-VALENTINE LEUCOCIDINE (PVL) | |
| GB201003924D0 (en) | Immunogenic composition | |
| ZA201503927B (en) | Immunogenic composition | |
| SG11201404447WA (en) | Immunogenic composition | |
| IL238079A0 (en) | Immunogenic preparation | |
| HUE064492T2 (hu) | Immunogén készítmény | |
| SG11201500979RA (en) | Immunogenic composition | |
| GB201223342D0 (en) | Immunogenic composition | |
| EP2609931A4 (en) | IMMUNOGENIC COMPOSITION | |
| GB201218660D0 (en) | Immunogenic composition | |
| GB201204968D0 (en) | Immunogenic composition | |
| GB201204851D0 (en) | Immunogenic composition | |
| GB201003918D0 (en) | Immunogenic composition |